Post-transplant diabetes mellitus (PTDM) reduces allograft and recipient life span. Polygenic
risk scores (PRSs) show robust association with greater risk of developing type 2 diabetes …

For more than a century, transplantation of tissues and organs from animals into man,
xenotransplantation, has been viewed as a potential way to treat disease. Ironically, interest …

In spite of reduction of rejection rates and improvement in short-term survival post–kidney
transplantation, modest progress has occurred in long-term graft attrition over the years …

Improvements in immunosuppression have modified short‐term survival of deceased‐donor
allografts, but not their rate of long‐term failure. Mismatches between donor and recipient …

Background: Polymorphisms in genes encoding for drug-metabolizing enzymes and drug
transporters are among multiple factors that modulate the pharmacokinetic variability of …

Despite significant improvement in the rates of acute allograft rejection, proportionate
improvements in kidney allograft longevity have not been realized, and are a source of …

Genome-wide association studies (GWAS) are designed to investigate single nucleotide
polymorphisms (SNPs) and the association with a clinical phenotype. A previous GWAS …

In kidney transplantation, short-term allograft survival has improved due to improvements in
acute rejection episodes without corresponding improvements in long-term survival …

Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ
transplantation. PTDM prevalence varies due to different diabetes definitions. Consensus …

This review is focused on present and future biomarkers, along with pharmacogenomics
used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could …